MA49903A
(en )
2020-06-24
SULPHONYLURIDES AND SULPHONYLTHIOURIDES AS NLRP3 INHIBITORS
MA48994A
(en )
2020-02-05
ISOQUINOLEINS USED AS HPK1 INHIBITORS
FR25C1047I1
(en )
2026-01-02
AMINOPYRAZOLES AS SELECTIVE JANUS KINASE INHIBITORS
MA45244A
(en )
2019-04-17
SUBSTITUTED PYRIDINES USED AS DNMT1 INHIBITORS
EP3386981A4
(en )
2019-06-19
HETEROCYCLES USEFUL AS ANTICANCER AGENTS
MA47460A
(en )
2019-12-18
AMINOTRIAZOLOPYRIDINES USED AS KINASE INHIBITORS
EP3563742A4
(en )
2020-08-05
CLEANSER
EP3353328A4
(en )
2019-06-12
MODULATORS OF KRAS EXPRESSION
EP3485790A4
(en )
2020-09-16
CLEANSER
MA41551A
(en )
2017-12-26
BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
MA40943A
(en )
2017-09-19
SUBSTITUTED PYRROLOPYRIDINES USED AS BROMODOMA INHIBITORS
MA52593A
(en )
2021-03-17
1H-PYRAZOLO [4,3-B] PYRIDINES AS PDE1 INHIBITORS
MA40940A
(en )
2017-09-19
SUBSTITUTED PYRROLOPYRIDINES USED AS BROMODOMA INHIBITORS
MA46981A
(en )
2019-10-09
BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
MA40774A
(en )
2017-08-08
DIARYLEUREA DERIVATIVES AS KINASE P38 INHIBITORS
EP3347008A4
(en )
2019-04-10
BETA-LACTAMASES INHIBITORS
MA44006A
(en )
2021-04-14
PDE1 INHIBITOR
EP3536211A4
(en )
2020-07-22
CLEANSER
ME03414B
(en )
2020-01-20
IMIDAZOPYRAZOLONE AS PDE1 INHIBITORS
EP3426636A4
(en )
2020-01-01
SUBSTITUTED HETEROCYCLES AS C-MYC TARGETING AGENTS
EP3487851A4
(en )
2019-12-25
AMINOPYRIDINE DERIVATIVES AND THEIR USE AS SELECTIVE ALK-2 INHIBITORS
EP3502111A4
(en )
2020-05-20
PDE4 INHIBITOR
MA44987A
(en )
2019-03-20
ENHANCED DRUG FORMULATIONS
EP3417845A4
(en )
2019-07-03
ALPHA-GEL FORMATION COMPOSITION AND ALPHA-GEL COMPOSITION
ITUA20162425A1
(en )
2017-10-08
Ophthalmic composition comprising PVP-I